Herbas VPB

Print
EN | LT
LT - COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
EN - COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/444
A61K 39/395
A61P 35/00
European patent
(11) Number of the document 1915151
(13) Kind of document T
(96) European patent application number 06739398.3
Date of filing the European patent application 2006-03-22
(97) Date of publication of the European application 2008-04-30
(45) Date of publication and mention of the grant of the patent 2011-08-17
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2006/010582
Date 2006-03-22
PCT application publication
(87) Number WO 2006/102504
Date 2006-09-28
Priority applications
(30) Number Date Country code
664381 P 2005-03-22 US
Inventors
(72)
CHANG, David, US
Grantee
(73) Amgen, Inc, Patent Operations, M/S 28-2-C One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Title
(54) COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
  COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
Last update date 2021-04-30